Main Menu Investigator-Initiated Studies Through the Investigator-Initiated Studies Program, Corcept Therapeutics provides support for research projects that advance medical and scientific knowledge about Corcept’s medications and their appropriate applications, with the goal of improving patient care. Depending on the type of study, Corcept may support investigator-initiated studies by providing medication, funding, and/or subject matter expertise. Submitting a Request Researchers are invited to submit their concept proposal via the submission portal. If the concept submission is of interest, a follow-up request for a full submission will be issued. A full submission must be received for a request to be considered for approval. Research & Pipeline Cortisol Modulation Cortisol Modulation Therapeutic Platform Pipeline and Clinical Trials Publications Investigator-Initiated Studies Compassionate Use Submit an Investigator-Initiated Study Request Through Our Portal SUBMISSION PORTAL About Executive Team Board of Directors Educational Grants Contact Us Product Korlym for Cushing Syndrome Medical Information Request Patients Research & Pipeline Cortisol Modulation Cortisol Modulation Therapeutic Platform Pipeline and Clinical Trials Publications Investigator-Initiated Studies Compassionate Use Investors Investors Overview Press Releases Events Corporate Governance Analyst Coverage Stock Information SEC Filings Careers Benefits Testimonials Current Opportunities © 2021 Corcept Privacy Policy Terms of Use Site Map We use cookies to evaluate and improve your user experience on our website, to analyze our website traffic, and for advertising purposes. To learn more about how we use cookies, and how to change your cookie settings, please visit our Privacy Policy. By continuing to use our site you consent to our use of cookies. ACKNOWLEDGED